Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 14, 2022NeuropharmacologyOpen Access

Arketamine, a new rapid-acting antidepressant: A historical review and future directions

View Full Paper
Ask AI
Bookmark
Share

Authors

WYWei YaoFujian Medical University
Kenji Hashimoto
Kenji HashimotoKurume University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yao et al. (2022) studied this question.

synapsesocial.com/papers/6a929593eba2c67b4da5f5b2https://doi.org/10.1016/j.neuropharm.2022.109219
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Short DNA/RNA heteroduplex oligonucleotide interacting proteins are key regulators of target gene silencing2021 · 11 citations
  2. 2A Positive Autoregulatory BDNF Feedback Loop via C/EBPβ Mediates Hippocampal Memory Consolidation2014 · 151 citations
  3. 3Activation of AP‐1 and CRE‐dependent gene expression via µ‐opioid receptor2004 · 33 citations
  4. 4Suppression of abnormal α-synuclein expression by activation of BDNF transcription ameliorates Parkinson’s disease-like pathology2022 · 38 citations
  5. 5Regulation of BDNF transcription by Nrf2 and MeCP2 ameliorates MPTP-induced neurotoxicity2022 · 48 citations